124 related articles for article (PubMed ID: 21840059)
1. Quantification of cerebral tumour blood flow and permeability with T1-weighted dynamic contrast enhanced MRI: a feasibility study.
Dujardin MI; Sourbron SP; Chaskis C; Verellen D; Stadnik T; de Mey J; Luypaert R
J Neuroradiol; 2012 Oct; 39(4):227-35. PubMed ID: 21840059
[TBL] [Abstract][Full Text] [Related]
2. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging.
Lüdemann L; Hamm B; Zimmer C
Magn Reson Imaging; 2000 Dec; 18(10):1201-14. PubMed ID: 11167040
[TBL] [Abstract][Full Text] [Related]
4. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
5. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
[TBL] [Abstract][Full Text] [Related]
7. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
8. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
[TBL] [Abstract][Full Text] [Related]
9. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.
Provenzale JM; Wang GR; Brenner T; Petrella JR; Sorensen AG
AJR Am J Roentgenol; 2002 Mar; 178(3):711-6. PubMed ID: 11856703
[TBL] [Abstract][Full Text] [Related]
10. Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI.
Cao Y; Shen Z; Chenevert TL; Ewing JR
J Magn Reson Imaging; 2006 Aug; 24(2):288-96. PubMed ID: 16795091
[TBL] [Abstract][Full Text] [Related]
11. Application of histogram analysis for the evaluation of vascular permeability in glioma by the K2 parameter obtained with the dynamic susceptibility contrast method: Comparisons with Ktrans obtained with the dynamic contrast enhance method and cerebral blood volume.
Taoka T; Kawai H; Nakane T; Hori S; Ochi T; Miyasaka T; Sakamoto M; Kichikawa K; Naganawa S
Magn Reson Imaging; 2016 Sep; 34(7):896-901. PubMed ID: 27109485
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
13. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI.
Sourbron S; Ingrisch M; Siefert A; Reiser M; Herrmann K
Magn Reson Med; 2009 Jul; 62(1):205-17. PubMed ID: 19449435
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Tumor Blood Flow Using Alternate Ascending/Descending Directional Navigation in Primary Brain Tumors: A Comparison Study with Dynamic Susceptibility Contrast Magnetic Resonance Imaging.
Park H; Lee J; Park SH; Choi SH
Korean J Radiol; 2019 Feb; 20(2):275-282. PubMed ID: 30672167
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
16. Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI.
Liu HL; Chang TT; Yan FX; Li CH; Lin YS; Wong AM
NMR Biomed; 2015 Jun; 28(6):642-9. PubMed ID: 25880892
[TBL] [Abstract][Full Text] [Related]
17. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
18. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers.
Awasthi R; Rathore RK; Soni P; Sahoo P; Awasthi A; Husain N; Behari S; Singh RK; Pandey CM; Gupta RK
Neuroradiology; 2012 Mar; 54(3):205-13. PubMed ID: 21541688
[TBL] [Abstract][Full Text] [Related]
19. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
[TBL] [Abstract][Full Text] [Related]
20. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging.
Zhu XP; Li KL; Kamaly-Asl ID; Checkley DR; Tessier JJ; Waterton JC; Jackson A
J Magn Reson Imaging; 2000 Jun; 11(6):575-85. PubMed ID: 10862055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
